 PHILADELPHIA, Aug. 23, 2021 GLOBE NEWSWIRE -- via Investor Wire AnPac Bio-Medical Science Co., Ltd. AnPac Bio, the Company or we NASDAQ: ANPC, a biotechnology company with operations in the United States and China, today announces that the Company filed with Chinas National Medical Products Administration NMPA on Aug. 19, 2021, for registration testing of its class III, multi-cancer detection medical device based on its Cancer Differentiation Analysis Technology CDA. 